The human body is an extremely complex molecular machine, the details of which can be followed through certain substances; so-called biomarkers. Unfortunately, it is not yet possible to monitor biomarkers live in patients when these are present in minuscule concentrations. Researchers at Eindhoven University of Technology have now developed a new technique that can become the plain and simple solution for the live and super-sensitive monitoring of biomarkers.
They report on it in Nature Communications.
Substances that are essential for the body, such as proteins and hormones, are present in the blood in pico- or nanomolar concentrations. These are concentrations comparable to 1 sugar grain dissolved in an Olympic-sized swimming pool – extremely low, and difficult to measure. In the Molecular Biosensing for Medical Diagnostics group at Eindhoven University of Technology, under the guidance of Professor Menno Prins, a sensing technology has been developed that enables the super-sensitive measurement of biomarker concentrations over time.
The technique is based on the fact that tiny particles in liquid are continuously in Brownian motion because water molecules collide with them. The researchers bound the particles through a nanostrand to a glass plate, causing the particles to wiggle back and forth. The biomarker to be measured binds temporarily to specific adhesive molecules that are fixed to both the particles and the plate. When a biomarker molecule attaches itself to both a wiggling particle and to the plate, the particle suddenly becomes attached, which greatly reduces its mobility – until the biomarker is released again.
The mobility of the particles, which are coupled to the transparent glass, could be easily observed by the researchers with light. They have given their technology the name BPM: Biomarker monitoring based on sensing of Particle Mobility. Every time a wiggling particle suddenly moves less, and then more, one biomarker molecule has been observed. The number of these events per minute reveals the concentration of the biomarker in the liquid with a high degree of sensitivity.
The principle is explained in this animation video: https:/
The beauty of the BPM sensor technology is that it has digital precision, and that both increases and decreases in biomarker concentration over time can be monitored. The technique has now been demonstrated for the monitoring of protein and DNA. The technology is widely applicable, because suitable adhesion molecules are available for almost all biomarkers.
This flexibility, combined with the sensitivity and the expected miniaturization of the technology, means that Prins and his fellow researchers have high expectations of the future for their technology. “We anticipate that a completely new class of sensors for the monitoring of biomarkers will emerge from this,” says the professor, so he is creating a start-up that will develop practical sensors and applications. One of the possibilities is to connect a sensor to a catheter with which patients in the operating room or in the intensive care unit can be accurately monitored. In addition to medical applications, Prins also thinks there are possibilities for monitoring biomolecules in industrial processes and water purification.
The Latest on: Monitoring of biomarkers
via Google News
The Latest on: Monitoring of biomarkers
- New studies support blood test for early detection of Alzheimer's diseaseon January 13, 2021 at 7:33 am
In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for ...
- Apple partners with Biogen to search for digital cognitive health biomarkers via Apple Watch and iPhoneon January 13, 2021 at 4:27 am
Apple has partnered with Biogen for a multi-year observational research study to investigate the use of the Apple Watch and iPhone to detect declining ...
- Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratorieson January 12, 2021 at 10:57 pm
HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners (“Arsenal”), announced today the acquisition of Mosaic Laboratories LLC (“Mosaic”), a ...
- Immune response biomarkers, novel pathways in four marine mollusk specieson January 12, 2021 at 2:17 pm
A new study assessed immune responses in four economically important marine mollusk species -- the blue mussel, soft-shell clam, Eastern oyster, and Atlantic jackknife clam -- and identified new ...
- Study identifies immune response biomarkers, novel pathways in four marine mollusc specieson January 12, 2021 at 8:16 am
A new study involving the University of Maine assessed immune responses in four economically important marine mollusc species -- the blue mussel, soft-shell clam, Eastern oyster, and Atlantic ...
- New study identifies immune response biomarkers, novel pathways to support Mollusca aquacultureon January 12, 2021 at 6:37 am
Understanding the immune systems of oysters and clams is important in monitoring the effects of pollution and climate change on the health of molluscan species and the potential impacts on the ...
- Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple ...on January 12, 2021 at 1:57 am
The study aims to identify digital biomarkers to help monitor cognitive performance and health including potentially detecting mild cognitive impairment, an early indicator of certain forms of ...
- Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhoneon January 11, 2021 at 2:24 pm
The study aims to identify digital biomarkers to help monitor cognitive performance and health including potentially detecting mild cognitive impairment, ...
- Biogen and Apple Announce Study to Investigate Role Apple Watch and iPhone Could Have in Monitoring Cognitive Healthon January 11, 2021 at 12:56 pm
Biogen and Apple have announced a new study that will investigate the role Apple Watch and iPhone could play in monitoring cognitive performance and screening for declines in cognitive health, ...
via Bing News